The latest news, announcements and press releases from Akron Bio.
Cambridge, UK and Boca Raton, FL – January 27, 2026 – Qkine Limited, a leading innovator in the development of high-quality growth factors and cytokines, and Akron Bio, a leading supplier of critical materials and services to the cell and gene therapy industry, today announced a strategic partnership focused on the joint development and global supply of ancillary materials to enable the development of stem cell-based therapeutics.
April 12, 2022 (Sarasota, Fla.) – Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, today launched a new, state-of-the-art cGMP (Current Good Manufacturing Practice) plasmid DNA manufacturing facility in Sarasota, Florida.
This is the News section of the company profile page for Akron Bio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
